These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1801738)

  • 21. In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.
    Otto MJ; Reid CD; Garber S; Lam PY; Scarnati H; Bacheler LT; Rayner MM; Winslow DL
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2606-11. PubMed ID: 8109924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection.
    Ankel H; Turriziani O; Antonelli G
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2797-800. PubMed ID: 1940869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase.
    Craig JC; Duncan IB; Hockley D; Grief C; Roberts NA; Mills JS
    Antiviral Res; 1991 Dec; 16(4):295-305. PubMed ID: 1810306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication.
    Bourinbaiar AS; Lee-Huang S
    FEBS Lett; 1995 Feb; 360(1):85-8. PubMed ID: 7875307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.
    Bartz SR; Hohenwalter E; Hu MK; Rich DH; Malkovsky M
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5381-5. PubMed ID: 7777516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.
    von der Helm K; Gürtler L; Eberle J; Deinhardt F
    FEBS Lett; 1989 Apr; 247(2):349-52. PubMed ID: 2469601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HIV replication by baicalin and S. baicalensis extracts in H9 cell culture.
    Zhang X; Tang X; Chen H
    Chin Med Sci J; 1991 Dec; 6(4):230-2. PubMed ID: 1813061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effect of branched polyethyleneimine (bPEI) on cells infected with human immunodeficiency virus: enhancement of viral replication.
    Kandi MR; Mohammadnejad J; Abdoli A; Amiran MR; Soleymani S; Aghasadeghi MR; Zabihollahi R; Baesi K
    Arch Virol; 2019 Dec; 164(12):3019-3026. PubMed ID: 31598843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between the in vitro and in vivo activity of anti-HIV agents: implications for future drug development.
    Yarchoan R; Broder S
    J Enzyme Inhib; 1992; 6(1):99-111. PubMed ID: 1285306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV protease inhibitors: effects on viral maturation and physiologic function in macrophages.
    Bugelski PJ; Kirsh R; Hart TK
    J Leukoc Biol; 1994 Sep; 56(3):374-80. PubMed ID: 8083611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dimethyl sulfoxide inhibits human immunodeficiency virus production in vitro.
    Viza D; Aranda-Anzaldo A; Zompetti C; Vich JM
    Intervirology; 1991; 32(1):59-64. PubMed ID: 1707866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro.
    Mellert W; Amtmann E; Erfle V; Sauer G
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):71-81. PubMed ID: 3365357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic effects of kijimicin on inhibition of human immunodeficiency virus replication.
    Yamauchi T; Nakamura M; Honma H; Ikeda M; Kawashima K; Ohno T
    Mol Cell Biochem; 1993 Feb; 119(1-2):35-41. PubMed ID: 8455584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral therapy.
    Oberg B
    J Acquir Immune Defic Syndr (1988); 1988; 1(3):257-66. PubMed ID: 3063807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of replication of human immunodeficiency virus by a heteropolyoxotungstate (PM-19).
    Inouye Y; Take Y; Tokutake Y; Yoshida T; Yamamoto A; Yamase T; Nakamura S
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):285-7. PubMed ID: 2337949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease.
    Kort JJ; Bilello JA; Bauer G; Drusano GL
    Antimicrob Agents Chemother; 1993 Jan; 37(1):115-9. PubMed ID: 8431007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How can HIV replication be controlled?
    Cohen J
    Science; 1993 May; 260(5112):1257. PubMed ID: 8333877
    [No Abstract]   [Full Text] [Related]  

  • 38. Kijimicin: an inhibitor of human immunodeficiency virus in acutely and chronically infected cells.
    Nakamura M; Ohno T; Kunimoto S; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1991 May; 44(5):569-71. PubMed ID: 2061199
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillin derived C2-symmetric dimers as novel inhibitors of HIV-1 proteinase.
    Humber DC; Cammack N; Coates JA; Cobley KN; Orr DC; Storer R; Weingarten GG; Weir MP
    J Med Chem; 1992 Aug; 35(16):3080-1. PubMed ID: 1501235
    [No Abstract]   [Full Text] [Related]  

  • 40. Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction.
    Dianzani F; Capobianchi MR; Antonelli G; Amicucci P; De Marco F
    Antiviral Res; 1989; 11(5-6):299-305. PubMed ID: 2802571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.